What You Need to Know About Johnson & Johnson's 2019 Third-Quarter Earnings
The 5 Stages of COVID-19 Vaccine Development: What You Need to Know About How a Clinical Trial WorksDid you like reading this story? Click the heart to show your love.
Johnson & Johnson Signs a Historic Pledge to Uphold the Integrity of the Scientific Process in Developing an Investigational COVID-19 VaccineClick the heart to show your support of this pledge.
The Impact of COVID-19 on a Company: 6 Questions for the Chief Financial Officer of Johnson & JohnsonDid you like reading this story? Click the heart to show your love.
This morning, Johnson & Johnson shared its third-quarter performance.
Since its founding in 1886, the company has grown to become one of the world's largest and most broadly based healthcare companies, with approximately 135,000 employees across the globe working every day to help change the trajectory of health for humanity.
“We delivered strong revenue and earnings growth during the third quarter, while also making strategic investments that advance our innovative pipeline across all three business segments,” says, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “Our colleagues around the world are passionate and committed to driving robust performance, while providing healthcare solutions that deliver long-term value to our patients, consumers, employees, communities and shareholders.”
For more details about the company's 2019 third-quarter results, and to read a comment from Chairman and Chief Executive Officer, here's an infographic that highlights key stats.
Want to see more company earnings information? Find several years of Johnson & Johnson’s quarterly and full-year results here.